We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Dried Urine Spots Detect Cytomegalovirus in Newborns

By LabMedica International staff writers
Posted on 21 Jun 2012
Dried urine spots (DUS) can be used to provide a simple screening tool for congenital Cytomegalovirus (CMV) infection in newborn infants. More...


A standardized method for CMV quantification from DUS has been developed that uses molecular technology to detect and quantify the viral load in urinary samples.

Scientists at Johns Hopkins Medical Institutions (Baltimore, MD, USA) collected and tested archived urine samples from 27 congenitally infected and 15 uninfected neonates. DNA was extracted using an automated method from urine samples placed on filter paper discs. A quantitative CMV real-time polymerase chain reaction (rt-PCR) assay was performed on the extracted DNA, spiked urine samples, and suitable control samples.

Urine samples from congenitally infected newborns and negative controls either were diluted 1:10 or applied on filter paper at the same volume. The analytical sensitivity was determined of 100% of replicates at 7,500 CMV copies/mL. The actual detection limit was 22 DNA copies/disc. DNA copy number from DUS correlated well with copy number from 1:10 diluted urine, although there was a trend for lower levels from DUS. Amplification was performed on a 7500 Real-Time PCR System (Applied Biosystems; Foster City, CA, USA).

Concentrations of CMV DNA in the 27 positive samples ranged from 4.4 to 8.8 log10 copies/mL, with a mean of 6.5 log10 copies/mL. Three samples had CMV DNA levels that were greater than the highest concentration of the spikes urine tested for measurable range calculation. This screening method could be used to detect the presence of congenital CMV infection by inserting a filter paper in the newborn's diaper and therefore for this purpose, quantification may not be necessary.

The authors concluded that the assay may provide a simple and rapid tool for CMV detection and quantification from DUS in underdeveloped or developing countries in which diagnostic capabilities for CMV are lacking. Information on CMV prevalence from resource-constrained areas is currently limited due to lack of diagnostic infrastructure. The study was published on June 1, 2012, in the journal Diagnostic Microbiology and Infectious Disease.

Related Links:
Johns Hopkins Medical Institutions
Applied Biosystems


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.